NFKB1 and melanoma: As TFG is primarily involved in the NF-kB (important in the inhibition of apoptosis and treatment resistance in melanomas) and MAPK (activation of this signaling pathway occurs in approximately 70% of melanomas) pathways, aberrations in this gene may be considered important in the tumorigenesis of melanomas.